4 Largecap Up to 25 Per Cent Above 52-Week Low Stocks to Watch for Future Multibagger Potential: Sun Pharma, Titan, Asian Paints and Hindustan Zinc

Up to 25 per cent above 52-week low stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Sun Pharma, Titan, Asian Paints and Hindustan Zinc meet that test, with market caps from Rs 2.19 lakh crore to Rs 4.22 lakh crore and Sun Pharma offering the fastest profit growth, 35.75% a year since FY22. Each of these companies has a share price within 25 per cent of its 52-week low, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.

This list covers companies with a share price within 25 per cent of its 52-week low, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, market capitalisation above Rs 1,00,000 crore, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening up to 25 per cent above 52-week low stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 28 October 2026 and are drawn from NSE and BSE data and company filings.

Click Here – Get Free Investment Predictions

What Are Up to 25 Per Cent Above 52-Week Low Stocks and Why Do They Attract Multibagger Interest?

Up to 25 per cent above 52-week low stocks are shares that trade close to their yearly bottom, within a quarter of the lowest price of the last year, while profit continues to grow. The four here cover pharmaceuticals, jewellery and watches, paints and zinc mining.

A stock priced near its yearly low with growing profit offers a modest entry point, because the market price has not yet caught up with the business. For up to 25 per cent above 52-week low stocks, both FY26 and the latest quarter showed growth. Whichever way you read up to 25 per cent above 52-week low stocks, the common thread is rising profit backed by complete financial data. A sensible way to study up to 25 per cent above 52-week low stocks is to look at profit growth, returns and valuation side by side. Below, each of up to 25 per cent above 52-week low stocks gets its own breakdown of growth, returns and valuation. Treat up to 25 per cent above 52-week low stocks as a research list, since share prices and rankings change with every earnings season.

Up to 25 Per Cent Above 52-Week Low Stocks at a Glance: Price, Market Cap, PE and ROE

Prices are closing prices as of 28 October 2026. Hindustan Zinc combines the lowest PE of the group, 12.84, with the highest return on equity, 61.13%.

Stock	CMP (Rs)	Market Cap (Rs Cr)	PE	Industry PE	ROE	Debt to Equity	52-Week Range (Rs)
Sun Pharmaceutical Industries	1,757.50	4,22,307	34.85	36.42	13.74%	0.06	1,583.70 to 2,046.90
Titan Company	4,337.90	3,93,523	68.32	46.75	32.31%	0.93	3,506.50 to 5,186.70
Asian Paints	2,284.60	2,26,015	46.73	42.98	20.24%	0.18	2,115.00 to 2,985.70
Hindustan Zinc	506.80	2,19,141	12.84	12.27	61.13%	0.39	412.25 to 609.05

Sun Pharma: 35.75% Profit CAGR Since FY22

Sun Pharmaceutical Industries is one of India's largest drugmakers and sells generic and specialty medicines in India and overseas. It reported FY26 revenue of Rs 61,673.94 crore, up 12.69% year on year, and net profit of Rs 11,564.52 crore, up 5.32%. Net profit has compounded at 35.75% a year since FY22, while revenue has grown 11.62% a year. Operating margin was 31.47% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.

In the June 2026 quarter, revenue rose 11.93% to Rs 16,023.50 crore and net profit grew 26.41% to Rs 2,910.80 crore. The share price has gained 110.81% over five years. Domestic institutions raised their holding from 20.23% in September 2025 to 22.27% in September 2026. The stock trades at a PE of 34.85 against an industry PE of 36.42, below the sector average, with a return on equity of 13.74%.

Titan: 23.26% Profit CAGR Since FY22

Titan Company runs the jewellery (Tanishq), watches (Titan), eyewear and fragrances businesses. It reported FY26 revenue of Rs 88,136 crore, up 44.62% year on year, and net profit of Rs 5,073 crore, up 52.02%. Net profit has compounded at 23.26% a year since FY22, while revenue has grown 32.00% a year. Operating margin was 10.06% in FY26.

The stock trades at a PE of 68.32 against an industry PE of 46.75, with a return on equity of 32.31%. In the June 2026 quarter, revenue rose 29.31% to Rs 21,502 crore and net profit grew 62.88% to Rs 1,777 crore. The share price has gained 72.39% over five years and 22.47% over the past year. Domestic institutions raised their holding from 12.78% in June 2025 to 15.34% in June 2026.

Asian Paints: Return on Equity of 20.24%

Asian Paints is India's largest paint maker and sells decorative and industrial paints, waterproofing and home decor products. It reported FY26 revenue of Rs 36,307.34 crore, up 5.31% year on year, and net profit of Rs 4,394.69 crore, up 18.46%. Net profit has compounded at 9.25% a year since FY22, while revenue has grown 5.34% a year. Operating margin was 20.87% in FY26. The debt-to-equity ratio is 0.18.

In the June 2026 quarter, revenue rose 18.09% to Rs 10,782.79 crore and net profit grew 39.60% to Rs 1,559.45 crore. Foreign investors raised their holding from 11.85% in June 2025 to 13.32% in June 2026. The stock trades at a PE of 46.73 against an industry PE of 42.98, with a return on equity of 20.24%.

Hindustan Zinc: Return on Equity of 61.13%

Hindustan Zinc is among the world's largest integrated zinc producers and also produces lead and silver. It reported FY26 revenue of Rs 41,934 crore, up 19.59% year on year, and net profit of Rs 13,832 crore, up 33.60%. Net profit has compounded at 9.48% a year since FY22, while revenue has grown 8.15% a year. Operating margin was 56.75% in FY26. The debt-to-equity ratio is 0.39.

The stock trades at a PE of 12.84 against an industry PE of 12.27, with a return on equity of 61.13%. The dividend yield is 1.93%. In the June 2026 quarter, revenue rose 74.70% to Rs 14,063 crore and net profit grew 144.81% to Rs 5,469 crore. Foreign investors raised their holding from 1.31% in September 2025 to 2.36% in September 2026.

Up to 25 Per Cent Above 52-Week Low Stocks: Financial Comparison on Growth and Margins

The table compares scale and growth across these up to 25 per cent above 52-week low stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.

Stock	Revenue (Rs Cr)	Net Profit (Rs Cr)	Revenue Growth (YoY)	4-Year Revenue CAGR	4-Year Net Profit CAGR	Operating Margin (Latest Quarter)
Sun Pharma	61,673.94	11,564.52	12.69%	11.62%	35.75%	32.52%
Titan	88,136	5,073	44.62%	32.00%	23.26%	14.61%
Asian Paints	36,307.34	4,394.69	5.31%	5.34%	9.25%	23.26%
Hindustan Zinc	41,934	13,832	19.59%	8.15%	9.48%	64.19%

Check the Univest Screener for live data on these up to 25 per cent above 52-week low stocks

Institutional Holding in Sun Pharma, Titan, Asian Paints and Hindustan Zinc

Institutional holding shows who is backing these up to 25 per cent above 52-week low stocks alongside the promoter. The table uses the latest reported quarter for each. Sun Pharma has the deepest institutional backing, with FII and DII together holding 36.63% as of September 2026. Domestic institutions increased their holding over the past year in Sun Pharma (from 20.23% to 22.27%) and Titan (from 12.78% to 15.34%).

Stock	Promoter	FII	DII	Public	Quarter
Sun Pharma	52.68%	14.36%	22.27%	10.70%	September 2026
Titan	52.90%	15.38%	15.34%	16.38%	June 2026
Asian Paints	52.63%	13.32%	20.77%	13.28%	June 2026
Hindustan Zinc	60.71%	2.36%	4.85%	32.07%	September 2026

Risks to Weigh in Up to 25 Per Cent Above 52-Week Low Stocks

Being careful with up to 25 per cent above 52-week low stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:

• Past growth may not repeat.
• Share prices can move sharply in either direction.
• Valuation: Titan trades at a PE of 68.32 against an industry PE of 46.75, so earnings need to keep growing to support the price.
• Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.

How to Choose Between Up to 25 Per Cent Above 52-Week Low Stocks

Picking from up to 25 per cent above 52-week low stocks comes down to four checks, applied in order.

1. Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
2. Compare each PE with the industry PE (12.27 to 46.75) and ask whether the growth rate justifies any gap.
3. Track net profit growth, the operating margin and the return on equity in every quarterly result.
4. Stagger entries across quarters and review institutional holding every reporting season.

Download the Univest iOS App or Univest Android App to track Sun Pharma, Titan, Asian Paints and Hindustan Zinc live prices.

Conclusion

Among up to 25 per cent above 52-week low stocks, Sun Pharma stands out for the fastest profit growth, 35.75% a year since FY22, Titan for 44.62% revenue growth in FY26, Asian Paints for 5.31% revenue growth in FY26 and Hindustan Zinc for the highest return on equity at 61.13%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing up to 25 per cent above 52-week low stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Up to 25 Per Cent Above 52-Week Low Stocks to Watch

Which are the best up to 25 per cent above 52-week low stocks to watch for multibagger potential?

Ans. Sun Pharma, Titan, Asian Paints and Hindustan Zinc are the 4 names this list highlights, with market caps of Rs 4,22,307 crore, Rs 3,93,523 crore, Rs 2,26,015 crore and Rs 2,19,141 crore respectively. Sun Pharma is notable for the fastest profit growth, 35.75% a year since FY22. Titan stands out for 44.62% revenue growth in FY26. Asian Paints offers 5.31% revenue growth in FY26. Hindustan Zinc brings the highest return on equity at 61.13%. These are watchlist names for up to 25 per cent above 52-week low stocks, not recommendations, so match each one to your own risk profile and time horizon.

Is Hindustan Zinc a good stock for long-term investors?

Ans. Hindustan Zinc has a return on equity of 61.13%, a PE of 12.84 against an industry PE of 12.27 and a market cap of Rs 2,19,141 crore. Net profit has compounded at 9.48% a year since FY22, and FY26 revenue rose 19.59% while June 2026 quarter net profit grew 144.81%. Long-term returns in up to 25 per cent above 52-week low stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.

Can Sun Pharma become a multibagger from here?

Ans. Sun Pharma has already gained 110.81% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in up to 25 per cent above 52-week low stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 35.75% a year since FY22, and FY26 revenue rose 12.69%. At a PE of 34.85 against an industry PE of 36.42, valuation should be checked against that growth before investing.

What is the market cap of Sun Pharma, Titan, Asian Paints and Hindustan Zinc?

Ans. As of 28 October 2026, Sun Pharma has a market cap of Rs 4,22,307 crore, Titan has a market cap of Rs 3,93,523 crore, Asian Paints has a market cap of Rs 2,26,015 crore and Hindustan Zinc has a market cap of Rs 2,19,141 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on up to 25 per cent above 52-week low stocks.

What are the risks of investing in up to 25 per cent above 52-week low stocks?

Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Titan trades at a PE of 68.32 against an industry PE of 46.75, so earnings growth needs to hold up.

Why is Titan trading at a PE of 68.32?

Ans. Titan's PE of 68.32 compares with an industry PE of 46.75. The market is paying a premium for a return on equity of 32.31%, profit growth of 23.26% a year since FY22 and latest-quarter profit growth of 62.88%, which also means the stock is more sensitive if growth slows. Investors in up to 25 per cent above 52-week low stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.

How much do institutions hold in Sun Pharma, Titan, Asian Paints and Hindustan Zinc?

Ans. As of the latest reported quarter, FII and DII together hold 36.63% of Sun Pharma (14.36% and 22.27%), 30.72% of Titan (15.38% and 15.34%), 34.09% of Asian Paints (13.32% and 20.77%) and 7.21% of Hindustan Zinc (2.36% and 4.85%). Rising institutional holding is a useful signal in up to 25 per cent above 52-week low stocks, though it should be read with earnings trends rather than on its own.